Navigation Links
Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting

investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

Aranesp prescribing information can be accessed by calling 800-772-6436 or by logging on to www.aranesp.com.

Contact

Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aranesp ``145 Study Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/25/2009).../PRNewswire/-- FromNovember16-18,Phonak,theleading...thesecondeditionoftheHearingCareforAdultsConferenc...econferencebroughttogetherleadingexpertsinagingand...swhoworkeverydaywitholderpeoplewithhearinglossfora...esearchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...USNewswire/--RemediumTechnologiesInc.,acompanydeve...g,wonfirstprizeand$10,000intheMostPromisingSecurit...anyofficialsannouncetoday. ,, Selectedfrommoret...hedtheirinventionattheGSCSecuritySummitconferenceh...w.remediumtechnologies.com )isdevelopingahigh-pres...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...evicesMarketAnalysisandForecaststo2015 ,, htt...ntal-Devices-Market-Analysis-and-Forecasts-to-2015...isandForecaststo2015 ,, Summary ,, Thisrep...arelatingtotheUSdentaldevicesmarket.Italsooffersde...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12National Council on Disability to Call for Emergency Management Changes for People with Disabilities 53736 1FileTrail Joins With Lexmark To Offer End to End RFID Enabled Item Management Tracking and Printing Solutions 53734 1FileTrail Joins With Lexmark To Offer End to End RFID Enabled Item Management Tracking and Printing Solutions 53734 2FileTrail Joins With Lexmark To Offer End to End RFID Enabled Item Management Tracking and Printing Solutions 53734 3FileTrail Joins With Lexmark To Offer End to End RFID Enabled Item Management Tracking and Printing Solutions 53734 4Bipartisan Panel of Industry NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 53732 1Bipartisan Panel of Industry NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 53732 2Bipartisan Panel of Industry NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 53732 3Bipartisan Panel of Industry NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 53732 4Bipartisan Panel of Industry NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 53732 5Bipartisan Panel of Industry NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 53732 6
...27 Kinex Pharmaceuticals LLC,announced today that...,testing. The study is entitled "A combined rising...Phase 1 study to evaluate safety, tolerability,and...nced malignancies that,are refractory to conventio...w family of targeted cancer treatments called prot...
...sons Learned from the Avandia Controversy, ALEXAN...iabetes live longer when they are treated for depr...of Diabetes Care, which,publishes on November 27, ...orial by U.S. Food and Drug,Administration (FDA) M...sons learned from the recent Avandia controversy a...
Other Medicine Technology:First Patient Dosed with KX2-391 in Phase 1 Clinical Trial 2Treating Depression Prolongs Life for Older People with Diabetes 2
(Date:11/25/2009)...ow-up period was too short to draw definite conclu... 25 (HealthDay News) -- In diabetic patients with ...difference in outcomes at one year whether patient...ing, British researchers report. , Bypass surge...tients with coronary artery disease. However, less...
(Date:11/25/2009)...n plagued by neurological symptoms, study finds ,...- Neurological side effects are among the potentia...lar cancer who were treated with cisplatin-based c... included 1,409 Norwegian men treated for unilater...k part in a follow-up survey conducted from 1998 t...
(Date:11/25/2009)...leImprovementShownforthe4thStraightYear ,, WA...ngCancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnua...fprogressbeingmadeagainstthislethaldiseaseinthesta...CA),theonlynationalorganizationdedicatedexclusivel...triskforlungcancer. ,, (Logo: http://www.newsco...
(Date:11/25/2009)... placed under the skin kill tumor cells, study fin...s) -- A cancer vaccine delivered in a fingernail-s...new study reports. , The method uses polymer di...with tumor-specific antigens and implanted under t...umors. The Harvard University scientists who devel...
(Date:11/25/2009)... BioSpace.com, the premier resource for...e third edition of the BioForest™ Hotbed Cam...lewood, CO (Vocus) November 25, 2009 -- BioSpace.c...and information, unveiled the third edition of the... , , ,This regional campaign is a promotional eff...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...PRNewswire-Asia-FirstCall/ -- SOKO Fitness & S...d the Grand Opening of Xinyang,Spa in Harbin, Nort... began,offering "pre-opening" services on December..., Xinyang Rd., Daoli District, Harbin, China. Bles...
...overnment Accountability Office (GAO) today announ... president for Health Information Technology, Well...ion Technology Policy Committee, a new advisory bo...iable information on a wide range of government ac...
...hat has enhanced public understanding of biomedica...n for Biomedical Research (FBR) announced today it... E. DeBakey Journalism Awards. The awards, named ...and responsible use of animal models leads to medi...
... risk from overdosing following the surgery, study...) -- A new study links painkillers to one in five ...gery (also known as lumbar fusion) to help relieve...dal analgesic poisoning compared to the other surg...
...onds for stock jeopardize shareholder interests? ,.... Bell, Chief Restructuring Officer, and the Board...es Reinwald, Chairman of the Cancer Cure Coalition...buyout of the company,s notes for its stock. The ...
...herapeutix, Inc. announced today that Mr. Richard ...harles Eye Unit, King Edward VII Hospital, Windsor...Europe with the company,s CE Mark approved I-ZIP(R...ldable IOL with wound-assisted implantation throug...
Other Medicine News:Health News:SOKO Fitness & Spa Group, Inc. Opens Xinyang Spa in Harbin 2Health News:Charles Kennedy, M.D., Vice President for Health Information Technology, WellPoint, Inc., Appointed to National Health I.T. Policy Committee 2Health News:Charles Kennedy, M.D., Vice President for Health Information Technology, WellPoint, Inc., Appointed to National Health I.T. Policy Committee 3Health News:Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards 2Health News:Post-Op Painkillers Tied to Deaths After Spinal Fusion 2Health News:I-Therapeutix Announces First Commercial Use of I-ZIP(R) Adherent Ocular Bandage for Clear Corneal Cataract Incisions 2
...latelet aggregation profiler combined with a stand...Microsoft WindowsTM, the PAP-4CD has real time, fo...st results, plus simplified data retrieval and dat...ogenic assays, von willebrand assay (Ristocetin co...
Cobas Integra 400 plus
Advia 2400
Iron FS Ferene
Medicine Products: